scholarly article | Q13442814 |
P50 | author | Peyman Ghorbani | Q57059794 |
Miriam Merad | Q64748184 | ||
Catharina Arnold-Schrauf | Q105276141 | ||
P2093 | author name string | Tim Sparwasser | |
Christian Thomas Mayer | |||
Franz Puttur | |||
Luciana Berod | |||
Philipp Stüve | |||
Amrita Nandan | |||
Christina Hesse | |||
Markus Dudek | |||
P2860 | cites work | Id2 expression delineates differential checkpoints in the genetic program of CD8α+ and CD103+ dendritic cell lineages | Q24617939 |
Essential role for CD103 in the T cell-mediated regulation of experimental colitis | Q24646106 | ||
Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity | Q27489852 | ||
Critical roles of interferon regulatory factor 4 in CD11bhighCD8alpha- dendritic cell development | Q28591631 | ||
A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism | Q29614266 | ||
Cancer immunotherapy via dendritic cells | Q29615444 | ||
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow | Q29615498 | ||
The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting | Q29618424 | ||
Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages | Q29620142 | ||
Directed antigen targeting in vivo identifies a role for CD103+ dendritic cells in both tolerogenic and immunogenic T-cell responses | Q30505427 | ||
Batf3-dependent CD11b(low/-) peripheral dendritic cells are GM-CSF-independent and are not required for Th cell priming after subcutaneous immunization | Q31040402 | ||
The origin and development of nonlymphoid tissue CD103+ DCs. | Q33590397 | ||
CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells | Q33615124 | ||
CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells | Q33623556 | ||
The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells | Q33902379 | ||
Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells | Q33902421 | ||
Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes | Q34522666 | ||
Steady-state and inflammatory dendritic-cell development | Q34591334 | ||
TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection | Q34807008 | ||
Layers of dendritic cell-mediated T cell tolerance, their regulation and the prevention of autoimmunity | Q36073220 | ||
Cross-presenting CD103+ dendritic cells are protected from influenza virus infection | Q36357778 | ||
Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming | Q36371607 | ||
GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells | Q36398839 | ||
Regulatory T cells, tumour immunity and immunotherapy | Q36430144 | ||
Re(de)fining the dendritic cell lineage. | Q36818027 | ||
Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes | Q36979954 | ||
Dendritic cell homeostasis | Q37157975 | ||
Origin and development of dendritic cells | Q37700819 | ||
Deciphering the transcriptional network of the dendritic cell lineage | Q37700905 | ||
The equivalents of human blood and spleen dendritic cell subtypes can be generated in vitro from human CD34(+) stem cells in the presence of fms-like tyrosine kinase 3 ligand and thrombopoietin | Q37727859 | ||
DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues | Q39374974 | ||
Origin of the lamina propria dendritic cell network | Q42117974 | ||
Mast cells, histamine, and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node | Q43190653 | ||
Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells | Q43647446 | ||
CX3CR1+ c-kit+ bone marrow cells give rise to CD103+ and CD103- dendritic cells with distinct functional properties | Q46891836 | ||
Existence of CD8α-like dendritic cells with a conserved functional specialization and a common molecular signature in distant mammalian species | Q47607521 | ||
The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis | Q47734606 | ||
Genetic tracing via DNGR-1 expression history defines dendritic cells as a hematopoietic lineage. | Q47762575 | ||
Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells | Q47915755 | ||
Generation of large numbers of pro-DCs and pre-DCs in vitro. | Q51921795 | ||
Cutting edge: B220+CCR9- dendritic cells are not plasmacytoid dendritic cells but are precursors of conventional dendritic cells. | Q51931375 | ||
Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. | Q52049353 | ||
Characterization of distinct conventional and plasmacytoid dendritic cell-committed precursors in murine bone marrow. | Q52088536 | ||
GM-CSF increases cross-presentation and CD103 expression by mouse CD8⁺ spleen dendritic cells. | Q53241637 | ||
The Acquisition of Antigen Cross-Presentation Function by Newly Formed Dendritic Cells | Q58757859 | ||
Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets | Q73785333 | ||
Distinct differentiation potential of blood monocyte subsets in the lung | Q79717943 | ||
CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions | Q80444912 | ||
Blood monocyte subsets differentially give rise to CD103+ and CD103- pulmonary dendritic cell populations | Q80752326 | ||
A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection | Q81675748 | ||
P433 | issue | 20 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dendritic cell | Q506253 |
P304 | page(s) | 3081-3091 | |
P577 | publication date | 2014-08-06 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow | |
P478 | volume | 124 |
Q95329486 | Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity |
Q75719938 | Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells |
Q41930681 | Antigen Cross-Presentation and T-Cell Cross-Priming In Cancer Immunology And Immunotherapy |
Q39616830 | Beta 1-integrin ligation and TLR ligation enhance GM-CSF-induced ALDH1A2 expression in dendritic cells, but differentially regulate their anti-inflammatory properties |
Q89663687 | CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection |
Q38825771 | Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells |
Q90690167 | Cellular cytotoxicity is a form of immunogenic cell death |
Q37217082 | Classical dendritic cells mediate fibrosis directly via the retinoic acid pathway in severe eye allergy |
Q52576096 | De Novo Fatty Acid Synthesis During Mycobacterial Infection Is a Prerequisite for the Function of Highly Proliferative T Cells, But Not for Dendritic Cells or Macrophages. |
Q35757278 | Defining Mononuclear Phagocyte Subset Homology Across Several Distant Warm-Blooded Vertebrates Through Comparative Transcriptomics. |
Q38796901 | Dendritic cell development-History, advances, and open questions. |
Q41927622 | Development, Diversity, and Function of Dendritic Cells in Mouse and Human |
Q35639002 | Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect |
Q61124859 | Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins |
Q91496410 | Engineering dendritic cell vaccines to improve cancer immunotherapy |
Q92628430 | Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy |
Q61118475 | FGL2 promotes tumor progression in the CNS by suppressing CD103 dendritic cell differentiation |
Q47151386 | GM-CSF Monocyte-Derived Cells and Langerhans Cells As Part of the Dendritic Cell Family |
Q36421554 | Generation and transcriptional programming of intestinal dendritic cells: essential role of retinoic acid |
Q52719538 | IL17A Regulates Tumor Latency and Metastasis in Lung Adeno and Squamous SQ.2b and AD.1 Cancer. |
Q37224568 | Immune checkpoint blockade reveals the stimulatory capacity of tumor-associated CD103(+) dendritic cells in late-stage ovarian cancer |
Q47113436 | Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer |
Q91304130 | Lipopolysaccharide impacts murine CD103+ DC differentiation, altering the lung DC population balance |
Q47621612 | Listeria monocytogenes Replicate in Bone Marrow-Derived CD11c+ Cells but Not in Dendritic Cells Isolated from the Murine Gastrointestinal Tract. |
Q39030292 | Metabolites: deciphering the molecular language between DCs and their environment. |
Q91291852 | Modular actin nano-architecture enables podosome protrusion and mechanosensing |
Q48261622 | Monitoring C3aR Expression Using a Floxed tdTomato-C3aR Reporter Knock-in Mouse. |
Q47868063 | Monitoring C5aR2 Expression Using a Floxed tdTomato-C5aR2 Knock-In Mouse. |
Q92660089 | NF-κB p50-deficient immature myeloid cell (p50-IMC) adoptive transfer slows the growth of murine prostate and pancreatic ductal carcinoma |
Q50076191 | NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control |
Q99589491 | NLRX1 is a key regulator of immune signaling during invasive pulmonary aspergillosis |
Q38853730 | Neonatal mice possess two phenotypically and functionally distinct lung-migratory CD103(+) dendritic cell populations following respiratory infection |
Q58620994 | Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells |
Q58801877 | Nuclear Receptor Nur77 Deficiency Alters Dendritic Cell Function |
Q99710851 | PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade |
Q64094862 | Rapid Downregulation of DAB2 by Toll-Like Receptor Activation Contributes to a Pro-Inflammatory Switch in Activated Dendritic Cells |
Q92704401 | STAT3 Inhibits CD103+ cDC1 Vaccine Efficacy in Murine Breast Cancer |
Q28393754 | Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation |
Q63101722 | Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination |
Q38759136 | The role of cDC1s in vivo: CD8 T cell priming through cross-presentation. |
Q38685422 | The trophic life cycle stage of the opportunistic fungal pathogen Pneumocystis murina hinders the ability of dendritic cells to stimulate CD4(+) T cell responses |
Q104111165 | Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death |
Q40130950 | Transcription factor Batf3 is important for development of CD8+ T-cell response against a phagosomal bacterium regardless of the location of antigen |
Q37468541 | Transcriptional Control of Dendritic Cell Development. |
Q60938475 | Type 1 Conventional CD103 Dendritic Cells Control Effector CD8 T Cell Migration, Survival, and Memory Responses During Influenza Infection |
Q47571709 | Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer. |